Metabolic Syndrome, Insulin Resistance, and Brachial Artery Vasodilator Function in Framingham Offspring Participants Without Clinical Evidence of Cardiovascular Disease

American Journal of Cardiology

Volumn 101, Issue 1, 2008, Pages 82-88

  Hamburg, Naomi M ^a   Larson, Martin G ^b,c   Vita, Joseph A ^a   Vasan, Ramachandran S ^a,b   Keyes, Michelle J ^b,c   Widlansky, Michael E ^a   Fox, Caroline S ^b,d   Mitchell, Gary F ^e   Levy, Daniel ^b   Meigs, James B ^f   Benjamin, Emelia J ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FRAMINGHAM HEART STUDY   (United States)

^c Boston University   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e CARDIOVASCULAR ENGINEERING INC   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EDUCATION PROGRAM; FEMALE; GENDER; GROUPS BY AGE; HOMEOSTASIS; HUMAN; HYPEREMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGENY; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

BLOOD FLOW VELOCITY; BRACHIAL ARTERY; FEMALE; HUMANS; HYPEREMIA; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, CARDIOVASCULAR; MULTIVARIATE ANALYSIS; VASODILATION;

EID: 37349031781     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.07.053     Document Type: Article

References (30)

1. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., and Salonen J.T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
2. Girman C.J., Rhodes T., Mercuri M., Pyorala K., Kjekshus J., Pedersen T.R., Beere P.A., Gotto A.M., and Clearfield M. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 93 (2004) 136-141
3. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults. (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
4. Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 106 (2002) 286-288
5. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care 27 (2004) 2444-2449
6. Widlansky M.E., Gokce N., Keaney Jr. J.F., and Vita J.A. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42 (2003) 1149-1160
7. Benjamin E.J., Larson M.G., Keyes M.J., Mitchell G.F., Vasan R.S., Keaney Jr. J.F., Lehman B.T., Fan S., Osypiuk E., and Vita J.A. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 109 (2004) 613-619
8. Rodriguez C.J., Miyake Y., Grahame-Clarke C., Di Tullio M.R., Sciacca R.R., Boden-Albala B., Sacca R.L., and Homma S. Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol 96 (2005) 1273-1277
9. Kuvin J.T., Patel A.R., Sidhu M., Rand W.M., Sliney K.A., Pandian N.G., and Karas R.H. Relation between high-density lipoprotein cholesterol and peripheral vasomotor function. Am J Cardiol 92 (2003) 275-279
10. Wheatcroft S.B., Williams I.L., Shah A.M., and Kearney M.T. Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 20 (2004) 255-268
11. Kannel W.B., Feinleib M., McNamara P.M., Garrison R.J., and Castelli W.P. An investigation of coronary heart disease in families. The Framingham Offspring study. Am J Epidemiol 110 (1979) 281-290
12. Abbott R.D., and McGee D.L. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease, Section 37: The Probability of Developing Certain Cardiovascular Diseases in Eight Years at Specified Values of Some Characteristics (1987), National Heart, Lung, and Blood Institute, Bethesda, MD
13. Mitchell G.F., Parise H., Vita J.A., Larson M.G., Warner E., Keaney Jr. J.F., Keyes M.J., Levy D., Vasan R.S., and Benjamin E.J. Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension 44 (2004) 134-139
14. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith Jr. S.C., Spertus J.A., and Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
15. Meigs J.B., Dupuis J., Herbert A.G., Liu C., Wilson P.W., and Cupples L.A. The insulin gene variable number tandem repeat and risk of type 2 diabetes in a population-based sample of families and unrelated men and women. J Clin Endocrinol Metab 90 (2005) 1137-1143
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
17. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16 (1999) 442-443
18. SAS Institute Inc. SAS Procedures Guide, Version 8 (1999), SAS Institute, Cary, NC
19. Brook R.D., Bard R.L., Rubenfire M., Ridker P.M., and Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 88 (2001) 1264-1269
20. Wang T.D., Chen W.J., Lin J.W., Chen M.F., and Lee Y.T. Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome. Am J Cardiol 93 (2004) 362-365
21. Sola S., Mir M.Q., Cheema F.A., Khan-Merchant N., Menon R.G., Parthasarathy S., and Khan B.V. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation 111 (2005) 343-348
22. Lteif A.A., Han K., and Mather K.J. Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation 112 (2005) 32-38
23. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
24. Sundstrom J., Vallhagen E., Riserus U., Byberg L., Zethelius B., Berne C., Lind L., and Ingelsson I. Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care 29 (2006) 1673-1674
25. Steinberg H.O., Chaker H., Leaming R., Johnson A., Brechtel G., and Baron A.D. Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest 97 (1996) 2601-2610
26. de Jongh R.T., Serne E.H., Ijzerman R.G., de Vries G., and Stehouwer C.D. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 109 (2004) 2529-2535
27. Balletshofer B.M., Rittig K., Enderle M.D., Volk A., Maerker E., Jacob S., Matthaei S., Rett K., and Haring H.U. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 101 (2000) 1780-1784
28. Meigs J.B., Hu F.B., Rifai N., and Manson J.E. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 291 (2004) 1978-1986
29. Tulis D.A., Unthank J.L., and Prewitt R.L. Flow-induced arterial remodeling in rat mesenteric vasculature. Am J Physiol 274 (1998) H874-H882
30. Steinberg H.O., and Baron A.D. Vascular function, insulin resistance and fatty acids. Diabetologia 45 (2002) 623-634